AGP Picks
View all

European Morning Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Morning Report.

Press releases published on September 24, 2026

What Tools Help Brands Optimize for Meta Muse? Azoma Sets Out How Brands Get Recommended by Meta's AI Shopping Agent
GoldHaven Intersects New Skarn Zone at Kuhn; Drilling Underway from Second Pad
Colb Launches Colbee, a Digital Financial AI Agent That Turns Conversation Into Onchain Transactions
Kyverna Therapeutics Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
Transaction in Own Shares
Fortuna CEO to present at Mining Forum Americas 2026
Igor Makarov to Sponsor Mayflower Gran Prix Cyprus 2026
LBS launches SARI Foundation Institute for Work, Careers and Longevity
Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders
VR Submits NOI Permit Amendment to Expand Drill Sites for its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada
BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa
Ona Therapeutics advances as a clinical-stage company and appoints Aleix Prat, MD, PhD, as Chief Medical Officer
TRON Surpasses $30T in Total Transaction Volume as it Secures its Place as Leading Chain for Stablecoins
Unikie presented the next phase of automated vehicle logistics with Audi
 Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress
BRE wprowadza 7. wersję BREEAM Refurbishment and Fit Out Commercial
Il Building Research Establishment (BRE) lancia la metodologia “BREEAM Refurbishment and Fit Out Commercial Version 7”
AMG Critical Materials N.V. Filed for Secondary Listing on the Frankfurt Stock Exchange
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Morning Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.